H HCA HEALTHCARE INC
| Market Cap | $105.51B |
| P/E Ratio | 16.67 |
| Forward P/E | 14.18 |
| Dividend Yield | 0.66% |
| Beta | 1.37 |
| 52W Range | $315.49 - $544.32 |
| # Hedge Funds | 6 |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
Hedge Fund Ownership
| Investor 6 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| First Eagle Investment Management First Eagle Investment Management | 3.00% | $1.70B | 3,646,152 | Reduce 6.97% |
| Viking Global Investors Viking Global Investors | 1.24% | $466.48M | 999,180 | Reduce 27.63% |
| Thomas Gayner Markel Group | 0.30% | $37.67M | 80,680 | Add 7.27% |
| Richard Pzena Pzena Investment Management | 0.14% | $47.07M | 100,830 | Reduce 0.23% |
| Bill Nygren Harris Associates LP | 0.11% | $84.52M | 181,042 | Reduce 18.38% |
| Glenn Greenberg Brave Warrior Advisors | 0.04% | $1.83M | 3,923 | — |
Insider Trading
| Insider Name of the company insider who made the trade 22 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| McAlevey Michael REVP & Chief Legal & Admin Off. | Sale | 1,694 | $533.37 | $903.54K | 18 Feb 2026 | 18 Feb 2026 |
| Berres JenniferSVP & Chief Human Res. Officer | Sale | 4,010 | $526.16 | $2.11M | 11 Feb 2026 | 12 Feb 2026 |
| Berres JenniferSVP & Chief Human Res. Officer | Sale | 4,010 | $503.00 | $2.02M | 11 Feb 2026 | 12 Feb 2026 |
| Wyatt Christopher F.SVP & Controller | Sale | 4,000 | $505.00 | $2.02M | 11 Feb 2026 | 12 Feb 2026 |
| Cuffe Michael S.EVP and Chief Clinical Officer | Sale | 1,500 | $498.09 | $747.14K | 03 Feb 2026 | 05 Feb 2026 |
| HAZEN SAMUEL NCEO | Sale | 120 | $497.18 | $59.66K | 03 Feb 2026 | 05 Feb 2026 |
| HAZEN SAMUEL NCEO | Sale | 4,293 | $498.12 | $2.14M | 03 Feb 2026 | 05 Feb 2026 |
| HAZEN SAMUEL NCEO | Sale | 6,189 | $500.02 | $3.09M | 03 Feb 2026 | 05 Feb 2026 |
| HAZEN SAMUEL NCEO | Sale | 14,716 | $502.95 | $7.40M | 03 Feb 2026 | 05 Feb 2026 |
| HAZEN SAMUEL NCEO | Sale | 5,162 | $498.80 | $2.57M | 03 Feb 2026 | 05 Feb 2026 |
| HAZEN SAMUEL NCEO | Sale | 7,395 | $500.69 | $3.70M | 03 Feb 2026 | 05 Feb 2026 |
| HAZEN SAMUEL NCEO | Sale | 5,002 | $502.15 | $2.51M | 03 Feb 2026 | 05 Feb 2026 |
| Samuel N HazenCEO | Sale | 120 | $497.18 | $59.66K | 03 Feb 2026 | 05 Feb 2026 |
| Samuel N HazenCEO | Sale | 7,395 | $500.69 | $3.70M | 03 Feb 2026 | 05 Feb 2026 |
| Samuel N HazenCEO | Sale | 5,002 | $502.15 | $2.51M | 03 Feb 2026 | 05 Feb 2026 |
| Michael S. CuffeEVP and Chief Clinical Officer | Sale | 1,500 | $498.09 | $747.14K | 03 Feb 2026 | 05 Feb 2026 |
| Samuel N HazenCEO | Sale | 4,293 | $498.12 | $2.14M | 03 Feb 2026 | 05 Feb 2026 |
| Samuel N HazenCEO | Sale | 5,162 | $498.80 | $2.57M | 03 Feb 2026 | 05 Feb 2026 |
| Samuel N HazenCEO | Sale | 6,189 | $500.02 | $3.09M | 03 Feb 2026 | 05 Feb 2026 |
| Samuel N HazenCEO | Sale | 14,716 | $502.95 | $7.40M | 03 Feb 2026 | 05 Feb 2026 |
| McAlevey Michael REVP & Chief Legal & Admin Off. | Sale | 3,892 | $473.79 | $1.84M | 05 Nov 2025 | 05 Nov 2025 |
| Michael R McaleveyEVP & Chief Legal & Admin Off. | Sale | 3,892 | $473.79 | $1.84M | 05 Nov 2025 | 05 Nov 2025 |
Frequently Asked Questions
What is HCA stock price today?
HCA HEALTHCARE INC (HCA) is currently trading at $471.84. The stock has a 52-week range of $315.49 to $544.32 and a market capitalization of $105.51B.
Is HCA a good stock to buy in 2026?
HCA HEALTHCARE INC has a P/E ratio of 16.7 (forward P/E: 14.2), a dividend yield of 0.66%, and 1-year performance of +36.1%. 6 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling HCA stock?
There have been 22 insider transactions for HCA in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has HCA stock performed over the past year?
HCA HEALTHCARE INC (HCA) has returned +36.1% over the past 12 months. The stock traded between $315.49 and $544.32 during this period, and is currently at $471.84.
Which hedge funds own HCA (HCA HEALTHCARE INC)?
6 tracked hedge funds currently hold HCA in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is HCA's market cap and valuation?
HCA HEALTHCARE INC (HCA) has a market capitalization of $105.51B. The trailing P/E ratio is 16.7 and forward P/E is 14.2. The stock is classified in the Healthcare sector.
What is HCA's revenue and profitability?
HCA HEALTHCARE INC reported revenue of $75.60B with net income of $6.78B and a profit margin of 0.09%. The stock has a beta of 1.37.
What sector is HCA in and who are its biggest institutional holders?
HCA HEALTHCARE INC (HCA) operates in the Healthcare sector. It is held by 6 tracked hedge funds. See the ownership table above for the complete list.